Delivery Order SPE2DB20D2014-SPE2DB24FC99T

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) covers the delivery of Repatha 140 mg/ml SureClick autoinjector medication. The $2,033.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Repatha 140 mg/ml SureClick autoinjectors. The $1,788.82 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to supply a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,358.40 delivery order contract is for the supply of Repatha 140 mg/mL SureClick injection medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,355.76 Firm Fixed Price delivery order covers the supply of Repatha 140 mg/mL SureClick injectors. The contract has a completion date of September 3, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick injection medication. The $1,016.82 firm fixed price delivery order has a completion date of September 14, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the provision of Repatha 140 mg/mL SureClick medical injectors. The $4,895.85 delivery order contract has a firm fixed-price pricing type and an ultimate completion date of February 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick injections. The $1,664.42 firm fixed-price delivery order has a completion date of March 6, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $19,654.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Repatha 140 mg/mL SureClick injection medication. It is a firm fixed-price contract with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Repatha 140 mg/ml SureClick injection medication. The contract is a Delivery Order with a Firm Fixed Price of $1,355.76 and an ultimate completion date of June 11, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick autoinjectors. The $1,126.44 fixed-price delivery order has a completion date of November 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC99T
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (140 mg/mL) SureClick (autoinjector) medication. The $2,033.64 firm-fixed-price delivery order has a completion date of September 12, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies to support federal healthcare programs, including those serving the military and veterans. This contract does not have a set-aside designation.

Generated 12/11/24, 9:28 AM